Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/6475
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRajput, Parth-
dc.contributor.authorPrajapati, Bhumika-
dc.contributor.authorJena, Prasant Kumar-
dc.contributor.authorSeshadri, Sriram-
dc.date.accessioned2016-06-09T05:26:34Z-
dc.date.available2016-06-09T05:26:34Z-
dc.date.issued2015-10-
dc.identifier.issn2155-952X-
dc.identifier.urihttp://hdl.handle.net/123456789/6475-
dc.descriptionJ Biotechnology Biomaterial, 2015;5-6p.en_US
dc.description.abstractAim: To study the effect of modulating the gut microflora by oral administration of spectrum specific antibiotics delivery in HSD induced obesity and insulin resistance. Methods: Rats were fed HSD with or without antibiotics for 60 days. The physiological and biochemical parameters, fecal microbiota composition, Short chain fatty acids (SCFAs), Liver biochemistry, histopathology and gene expression of various G-protein coupled receptors (GPCRs) and various adipokines were investigated. Results: Simultaneous administration of HSD and antibiotics has shown significant improvements in glucose tolerance and obesity associated parameters like hypercholesterolemia and hypertryglyceremia as compared to HSD. The qPCR study of fecal samples showed increased in gram positive bacteria and reduction in gram negative bacteria which shows that restoration of commensal microflora in direction to improvement in obesity and insulin sensitivity. Treatment had reduced the effect of lipopolysaccharide content which further reduced immune receptors, GPCRs expression along with reduced the expression of proinflammatory cytokines. Gut microbiota manipulation towards decreased inflammation anen_US
dc.language.isoen_USen_US
dc.publisherOmics Onlineen_US
dc.subjectFaculty Paperen_US
dc.subjectFaculty Paper, Scienceen_US
dc.subjectScience, Faculty Paperen_US
dc.subjectGut Microbiotaen_US
dc.subjectObesityen_US
dc.subjectType 2 Diabetesen_US
dc.titleThe role of gut microbiota produced short chain fatty acids (SCFAs) in adiposity and inflammation in obesity and type 2 diabetesen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
109.pdf109295.96 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.